Gründling M, Kuhn S O, Riedel T, Feyerherd F, Wendt M
Klinik und Poliklinik für Anästhesiologie und Intensivmedizin, Medizinischen Fakultät der Ernst-Moritz-Arndt-Universität Greifswald.
Anaesthesiol Reanim. 1998;23(2):32-6.
Percutaneous dilatational tracheostomy is an increasingly accepted procedure for bed-side tracheostomy. The exact positioning of the endotracheal tube, the localization of the point for puncturing the trachea and damage to the endotracheal tube and the cuff as well as to the bronchoscope due to the puncturing process are technical problems which can endanger the course of the operation. In a prospective randomized study, we examined whether use of the laryngeal mask airway (LMA) is a real alternative to the endotracheal tube during tracheostomy. Of 48 consecutive patients only 43 fulfilled all criteria for this study: PaO2 > 100 mmHg, PaCO2 < 45 mmHg (in patients with head injury < 35 mmHg) under intermittent positive pressure ventilation (IPPV) with a mean ventilation pressure of < 25 mmHg and an FiO2 of 1.0. Patients with intestinal obstruction, hemorrhages of the mouth and nose and unfavourable anatomic conditions were not included in this study. Three more patients had to be excluded from the study because of technical problems. In 21 patients tracheostomy was performed using an endotracheal tube (ET group) and in 19 patients using a LMA (LM group). After positioning of the endotracheal tube or the LMA, tracheostomy was performed in the usual way. Arterial blood gases (PaO2 and PaCO2) were investigated before positioning of the endotracheal tube or the LMA, five minutes after this procedure and five minutes after the end of tracheostomy. Mean arterial pressure (MAP), heart frequency (HF) and peripheral oxygen saturation (SpO2), endexpiratory CO2 partial pressure (PetCO2) and minute ventilation volume (MVV) were registered every 60 seconds. The ET group and LM group did not differ regarding basic diseases, age and severity of illness. Before the beginning of tracheostomy, there were no differences in MAP, HF, SpO2, PetCO2 and PaCO2 between the two groups. Before tracheostomy, only PaO2 was significantly higher in the LM group than in the ET group. Immediately before the insertion of the tracheal cannula and five minutes after the end of tracheostomy, there were no differences in the measured parameters of the two groups. An increase in PetCO2 and a decrease in minute ventilation volume were observed in both groups. Regarding technical complications, the LMA is a safe alternative to the endotracheal tube. The choice of method should depend on the basic disease and the patient's ventilation requirements at the time of tracheostomy, while there is still a call for safe instruments guaranteeing sufficient sealing of the respiratory tract during the dilatational tracheostomy and simultaneous avoidance of technical problems during puncturing of the trachea and widening of the point of puncturing.
经皮扩张气管切开术是一种越来越被认可的床旁气管切开方法。气管内导管的准确定位、气管穿刺点的定位以及穿刺过程中对气管内导管、套囊和支气管镜的损伤等技术问题,都可能危及手术进程。在一项前瞻性随机研究中,我们探讨了在气管切开术中使用喉罩气道(LMA)是否真的可以替代气管内导管。在连续的48例患者中,只有43例符合本研究的所有标准:在间歇正压通气(IPPV)下,平均通气压力<25 mmHg且吸入氧浓度为1.0时,动脉血氧分压(PaO2)>100 mmHg,动脉血二氧化碳分压(PaCO2)<45 mmHg(头部受伤患者<35 mmHg)。肠梗阻、口鼻出血以及解剖条件不佳的患者未纳入本研究。另外3例患者因技术问题被排除在研究之外。21例患者使用气管内导管进行气管切开术(ET组),19例患者使用喉罩气道进行气管切开术(LM组)。在放置气管内导管或喉罩气道后,以常规方式进行气管切开术。在放置气管内导管或喉罩气道前、放置后5分钟以及气管切开术结束后5分钟,检测动脉血气(PaO2和PaCO2)。每60秒记录平均动脉压(MAP)、心率(HF)、外周血氧饱和度(SpO2)、呼气末二氧化碳分压(PetCO2)和分钟通气量(MVV)。ET组和LM组在基础疾病、年龄和病情严重程度方面无差异。在气管切开术开始前,两组的MAP、HF、SpO2、PetCO2和PaCO2无差异。在气管切开术前,只有LM组的PaO2显著高于ET组。在插入气管套管前及气管切开术结束后5分钟,两组的测量参数无差异。两组均观察到PetCO2升高和分钟通气量降低。关于技术并发症,喉罩气道是气管内导管的一种安全替代方法。方法的选择应取决于基础疾病和气管切开时患者的通气需求,同时仍需要安全的器械,以确保在扩张气管切开术期间呼吸道充分密封,并同时避免气管穿刺和穿刺点扩大过程中的技术问题。